4//SEC Filing
Haigh Adrian 4
Accession 0001415889-24-011336
CIK 0001211583other
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 7:34 PM ET
Size
14.4 KB
Accession
0001415889-24-011336
Insider Transaction Report
Form 4
Haigh Adrian
Director
Transactions
- Sale
Common Shares
2024-04-22$9.32/sh−22,223$207,029→ 0 total - Exercise/Conversion
Common Shares
2024-04-19$2.31/sh+22,222$51,333→ 22,222 total - Exercise/Conversion
Option
2024-04-22$2.31/sh−22,223$51,335→ 360,246 totalExercise: $2.31From: 2014-04-25Exp: 2024-04-25→ Common Shares (22,223 underlying) - Exercise/Conversion
Common Shares
2024-04-22$2.31/sh+22,223$51,335→ 22,223 total - Sale
Common Shares
2024-04-19$9.34/sh−22,222$207,442→ 0 total - Exercise/Conversion
Option
2024-04-19$2.31/sh−22,222$51,333→ 382,469 totalExercise: $2.31From: 2014-04-25Exp: 2024-04-25→ Common Shares (22,222 underlying)
Footnotes (6)
- [F1]Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
- [F2]Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
- [F3]Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
- [F4]Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
- [F5]Represents option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
- [F6]Represents option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001717425
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 7:34 PM ET
- Size
- 14.4 KB